Astellas Pharma is focusing on diversification, with its portfolio spanning cancer, vision loss and menopause treatments. Its Chief Medical Officer, Tadaaki Taniguci, said the company was also expanding its gene therapy output, using acquisitions and licensing to build capability, while in oncology, the firm’s lead drugs include treatments for prostate and bladder cancer. Astellas is also testing a small molecule for treating menopause symptoms.

How CISOs And SOC Heads Can Protect The Organization
Social engineering dominates modern cybersecurity, exploiting human psychology to breach systems despite advanced defenses. Techniques like phishing are prevalent. CISOs must foster vigilance through continuous